Latvian medicines producer Olainfarm turned over 110.7 million Euros and made an 11.6 million Euro profit in 2016, according to the company’s audited consolidated 2016 statement to Nasdaq Riga.
According to the statement, the pharmaceutical group’s annual sales grew 14 per cent last year to 110.7 million Euros. The group’s net profit in 2016 was 11.6 million Euros, which represents a reduction of 24 per cent compared to 2015, when the profit record of 15.3 million Euros was set. The profit of 2016 was considerably adversely influenced by provisions...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our
SUBSCRIPTION section
